LANDOS BIOPHARMA, INC.
1800 Kraft Drive, Suite 216
Blacksburg, VA 24060
|Februaruy 1, 2021||VIA EDGAR|
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn: Jenn Do
RE: Landos Biopharma, Inc.
Registration Statement on Form S-1
File No. 333-252083
Requested Date: February 3, 2021
Requested Time: 4:00 P.M. Eastern Time
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the Registrant) hereby requests that the Securities and Exchange Commission take appropriate action to cause the above-referenced Registration Statement on Form S-1 (the Registration Statement) to become effective on February 3, 2021, at 4:00 p.m., Eastern Time, or as soon thereafter as is practicable.
Once the Registration Statement has been declared effective, please orally confirm that event with Madison Jones, counsel to the Registrant, at (202) 728-7087.
Very truly yours,
Landos Biopharma, Inc.
|Chairman, President and Chief Executive Officer|
cc: Eric Blanchard, Cooley LLP
Madison Jones, Cooley LLP